证券之星消息,根据市场公开信息及4月3日披露的机构调研信息,国金基金近期对2家上市公司进行了调研,相关名单如下:1)瑞普生物 (国金基金参与公司分析师会议&路演活动)调研纪要:瑞普生物2024年经营活动产生的现金流量净额7.35亿,较上年同期增长79.35%,主要得益于下游养殖行业景气度提升和加强应收账款管理。2025-2026年公司将推出多联多价疫苗、基因工程苗、mRNA疫苗等新产品,并在宠物大...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.